课题基金 / 基金详情

Nuclear Transcription Factor Translocation Assay

Nuclear Transcription Factor Translocation Assay
核转录因子易位测定
批准号:
6689115
负责人:
PYARE L KHANNA
金额:
$10.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-07-01 至 2004-04-30

项目摘要

项目成果

PYARE L KHANNA的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):转录因子(TF)是基因表达的关键调控因子。大多数tf驻留在细胞质中,当被激活时转移到细胞核以刺激基因活性。在治疗上重要的TF是NFkappaB,它刺激参与细胞循环、增殖和炎症反应的基因,是开发抗癌和抗炎药物的重要分子靶点。由于核易位是NFkappaB调节基因表达能力的关键事件,因此测量NFkB易位的技术可用于筛选阻断易位过程的新型抗肿瘤和抗炎药物。然而,很少有技术来测量tf从细胞质溶胶到细胞核的运动,而且没有一种技术适用于高通量药物发现。DiscoveRx开发了一种酶片段互补(EFC)技术,该技术可用于使用极其敏感的β -半乳糖苷酶(β -gal)互补测定来检测tf的易位。这种方法利用了大肠杆菌β -gal的两个基因工程片段。较大的片段,被称为酶受体(EA),包含氨基末端附近的缺失,而较小的片段,被称为酶供体(ED),包含EA缺失的氨基末端序列。单独,EA是无活性的。然而,它可以与ED重组形成一种活性酶,该酶可以催化荧光产物的形成,通过光度法检测到,作为视觉放大的响应。我们建议使用EFC技术开发一种NFkB易位的直接检测方法。我们将把ED改造成NFkB,并将EA定位于细胞核。当ED-NFkappaB易位到细胞核时,它将能够与EA重组产生一个活性的B-gal,可以催化荧光产物的形成。作为测量NFkB易位的补充方法,我们将使用我们的EFC技术开发一种新的NFkappaB报告基因检测,其中NFkB应答元件驱动GST-ED融合蛋白的产生,该蛋白的表达将在简化的基于细胞的荧光检测中用EA检测。这些研究将开发第一个用于药物发现的NFkB易位。在未来,我们将采用这种方法作为针对任何TF的药物发现的通用技术,开辟转录因子和治疗的全新领域。
英文摘要
DESCRIPTION (provided by applicant): Transcription factors (TF) are key regulators of gene expression. Most TFs reside in the cytosol and when activated translocate to the nucleus to stimulate gene activity. A therapeutically important TF is NFkappaB, which stimulates genes involved in cell cycling, proliferation and inflammatory responses and is an important molecular target for the development of anti-cancer and anti-inflammatory drugs. Since nuclear translocation is a critical event in NFkappaB's ability to regulate gene expression, technologies that measure NFkB translocation could be used to screen for novel anti-neoplastic and anti-inflammatory agents that block the translocation process. However, there are few technologies to measure the movement of TFs from the cytosol to the nucleus and none that is amenable for high throughput drug discovery. DiscoveRx has developed an enzyme fragment complementation (EFC) technology that could be used to detect the translocation of TFs using an extremely sensitive beta-galactosidase (beta-gal) complementation assay. This method utilizes two genetically engineered fragments of E. coli beta-gal. The larger fragment, termed Enzyme Acceptor (EA), contains a deletion near the amino terminus, while the smaller fragment, termed Enzyme Donor (ED), contains the amino-terminal sequence missing from EA. Alone, EA is inactive. However, it can recombine with ED to form an active enzyme that can catalyze the formation of a fluorescent product detected photometrically as a visually amplified response. We propose to develop a direct assay for NFkB translocation using EFC technology. We will engineer ED into NFkB and target EA to the nucleus. When ED-NFkappaB translocates to the nucleus it will be able to recombine with EA to generate an active B-gal that can catalyze the formation of fluorescent products. As a complementary approach to measure NFkB translocation, we will develop a novel NFkappaB reporter gene assay using our EFC technology in which an NFkB response element drives the production of a GST-ED fusion protein whose expression will be detected with EA in a simplified cell based fluorescent assay. These studies will develop the first NFkB translocation for drug discovery. In the future, we will adapt this assay as a general technology for drug discovery against any TF to open up an entirely new field of transcription factor Dharmacoloav and therapeutics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HTS Technology for Discovery of Drugs Targeting GPCR Oligomers
  • 批准号:
    7169394
  • 项目类别:
  • 资助金额:
    $15.63万
  • 财政年份:
    2006
  • 负责人:
    PYARE L KHANNA
  • 依托单位:
Novel Drug Screening Assays for Orphan GPCRs
  • 批准号:
    7162821
  • 项目类别:
  • 资助金额:
    $15.12万
  • 财政年份:
    2006
  • 负责人:
    PYARE L KHANNA
  • 依托单位:
HTS Cell Based EFC Assays for GPCR Drug Discovery(RMI)
  • 批准号:
    7018985
  • 项目类别:
  • 资助金额:
    $14.43万
  • 财政年份:
    2005
  • 负责人:
    PYARE L KHANNA
  • 依托单位:
EFC Assay to Measure Growth Factor Receptors
  • 批准号:
    6831849
  • 项目类别:
  • 资助金额:
    $13.14万
  • 财政年份:
    2004
  • 负责人:
    PYARE L KHANNA
  • 依托单位:
海外基金